The legislation is a Senate version of the bill introduced by Rep. Doris Matsui (D-Calif.) that seeks to ensure drug companies cannot impose conditions on 340B discounts through pharmacy partners. Drug companies that violate these requirements would be subject to fines as high as $2 million per day.
340B Health President and CEO Maureen Testoni praised the bill, stating that it helps combat drugmaker policies that harm patient care in safety-net hospitals.
“We call on members of Congress … to support this crucial legislation for the benefit of the patients who have access to vital care and support because of 340B,” said Ms. Testoni.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.